Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Adv Drug Deliv Rev. 2016 Jun 4;113:61–86. doi: 10.1016/j.addr.2016.05.023

Fig. 8.

Fig. 8

MRI of magnetic NPs predicts therapeutic NP efficacy. Left: Example cross-sectional T2 images of tumors accumulating low and high intratumoral magnetic NP, with a pseudo-color overlay to indicate the difference in T2 within the manually segmented tumor region. Right: Pre-therapeutic MRI of magnetic NPs predicts accumulation and response to paclitaxel-loaded NPs. Tumor progression in HT1080 tumors was ranked according to low, medium, and high magnetic NP values as measured by MRI. Error bars denote S.E.M. (total n=33). Modified from ref. [Miller et al., 2015, Sci Transl Med, 7, 314ra183].